Biomarin Pharmaceutical (bmrn 1.25 05/15/27)
13F holders, Q2 2024 (June 30)18holders +3
6new positions
3sold out
$6.48avg. 13F price*
At the end of Q2 2024, 18 institutions reported holding Biomarin Pharmaceutical (bmrn 1.25 05/15/27) in their 13F filings, up 3 from Q1 2024. 6 opened new positions and 3 sold out. The largest holders were Loomis Sayles & Co. L P ($178.8M), Thrivent Financial for Lutherans ($13.0M) and Sonora Investment Management Group, LLC ($9.9M).
- Company
- Biomarin Pharmaceutical (bmrn 1.25 05/15/27)
- CUSIP
- 09061GAK7
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $348K |
| Exits | 3 | $7.0M |
All 13F filers, Q1 2024 → Q2 2024: 2,127,355 shares bought and 8,736,000 shares sold, net −6,608,645 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 18 holders
| Loomis Sayles & Co. L P | 0.25% | Add +4.0% | 2,172,135 | $178.8M |
| Thrivent Financial for Lutherans | 0.03% | Add +13.3% | 13,625,000 | $13.0M |
| Sonora Investment Management Group, LLC | 0.78% | No change | 9,930,000 | $9.9M |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 0.01% | Reduce -34.1% | 2,900,000 | $2.8M |
| Liberty Mutual Group Asset Management Inc. | 0.14% | No change | 1,025,000 | $979K |
| Ofi Invest Asset Management | 0.02% | Reduce -0.1% | 1,000,000 | $894K |
| Sei Investments Co. | 0.00% | Reduce -19.8% | 524,000 | $500K |
| Bank of New York Mellon Corp | 0.00% | No change | 300,000 | $287K |
| Oppenheimer Asset Management Inc. | 0.00% | New | 205,000 | $196K |
| Cetera Investment Advisers | 0.00% | Add +67.5% | 196,000 | $187K |
| Stephens Inc. | 0.00% | New | 106,000 | $101K |
| Choreo, LLC | 0.00% | New | 25,000 | $24K |
| Cerity Partners LLC | 0.00% | New | 21,000 | $20K |
| Capital Investment Advisors, LLC | 0.00% | No change | 11,000 | $11K |
| DAVENPORT & Co LLC | 0.00% | No change | 10,000 | $10K |
| Envestnet Asset Management Inc. | 0.00% | No change | 10,000 | $10K |
| EverSource Wealth Advisors, LLC | 0.00% | New | 7,000 | $7K |
| Intellectus Partners, LLC | 0.00% | New | 264 | $252 |
"% of holder's portfolio" is BIOMARIN PHARMACEUTICAL (BMRN 1.25 05/15/27)'s weight in each manager's 13F, not the share of Biomarin Pharmaceutical (bmrn 1.25 05/15/27) the manager owns.